Overview
NICE is unable to recommend the use in the NHS of tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia. This is because Lilly did not provide an evidence submission.
Last reviewed: 23 January 2013
Next review: We will review this decision if the company decides to make a submission.